- Q2 EBIT 4% below FactSet consensus on lower margin - We lower our '24e-'26e EBIT estimates by 7-3%...
- Sales and EBITDA in line with ABGSCe - Simplicity and predictability likely to drive limited cons.
Redeye see a Q2 report from Stille aligning with our estimates in terms of both sales and profitabil...
Redeye provides a short comment on Ortoma’s Q2 report this morning.
- Sales +3% and adj. EBIT +18% vs. ABGSCe - Operating cash flow SEK -19m, vs ABGSCe SEK -80m - Minor...
- Sales -6% y-o-y, -12% vs. ABGSCe - EBIT of SEK 49m, +12% vs.
Redeye comments on SHH´s second quarter of the year.
- Net sales SEK 191m, 3% vs ABGSCe, 2% vs Factset cons.
Fiskars Q2 adjusted EBIT of EUR 19.2m came 3% above LSEG Data & Analytics consensus expectations.
Svedbergs Group posted a solid set of Q2 2024 numbers, with sales coming in-line with our estimates ...
- Net sales SEK 562m, 0% vs ABGSCe and Factset cons.
Redeye states that Enea showed in Q2 that organic growth is here to stay, delivering +14% y/y growth...
Atria reported Q2 adjusted EBIT of EUR 18.4m, 47% (EUR 5.
Cibus' Q2 2024 income from property management (IFPM) was 6% above Infront consensus, but the result...
- '24e-'26e adj. EBITA down 3-2% - Increasingly likely that Q3'24 will be the trough - NTM EV/EBITA ...
- Higher sales and gross margin in Q2 - EBITDA revised up 2.
Redeye strengthens its positive view of Vertiseit following a Q2 report that exceeds our expectation...
- Rec. PTP 7% below ABGSCe - CEPS est. +2.7-0.6% for '25-26e due to projects - Share trading at a ~3...
Cibus posted Q2 results largely in line with expectations.
Despite a softer period for Vitrolife’s typically reliable Consumables and APAC, the company deliver...
